QQQ   266.42 (-1.44%)
AAPL   107.43 (-2.64%)
MSFT   198.83 (-2.01%)
FB   253.25 (-0.62%)
GOOGL   1,454.17 (-2.21%)
AMZN   2,949.35 (-1.97%)
NVDA   487.62 (-2.19%)
TSLA   440.00 (+3.91%)
BABA   274.00 (-0.62%)
CGC   16.49 (+0.55%)
GE   7.00 (-0.71%)
MU   50.99 (+0.02%)
AMD   74.92 (-2.13%)
T   29.05 (-0.07%)
F   7.29 (+0.14%)
ACB   6.62 (-3.92%)
GILD   64.70 (-0.52%)
NFLX   466.00 (-0.89%)
DIS   129.83 (-0.30%)
BAC   25.50 (+0.59%)
BA   164.62 (-1.74%)
QQQ   266.42 (-1.44%)
AAPL   107.43 (-2.64%)
MSFT   198.83 (-2.01%)
FB   253.25 (-0.62%)
GOOGL   1,454.17 (-2.21%)
AMZN   2,949.35 (-1.97%)
NVDA   487.62 (-2.19%)
TSLA   440.00 (+3.91%)
BABA   274.00 (-0.62%)
CGC   16.49 (+0.55%)
GE   7.00 (-0.71%)
MU   50.99 (+0.02%)
AMD   74.92 (-2.13%)
T   29.05 (-0.07%)
F   7.29 (+0.14%)
ACB   6.62 (-3.92%)
GILD   64.70 (-0.52%)
NFLX   466.00 (-0.89%)
DIS   129.83 (-0.30%)
BAC   25.50 (+0.59%)
BA   164.62 (-1.74%)
QQQ   266.42 (-1.44%)
AAPL   107.43 (-2.64%)
MSFT   198.83 (-2.01%)
FB   253.25 (-0.62%)
GOOGL   1,454.17 (-2.21%)
AMZN   2,949.35 (-1.97%)
NVDA   487.62 (-2.19%)
TSLA   440.00 (+3.91%)
BABA   274.00 (-0.62%)
CGC   16.49 (+0.55%)
GE   7.00 (-0.71%)
MU   50.99 (+0.02%)
AMD   74.92 (-2.13%)
T   29.05 (-0.07%)
F   7.29 (+0.14%)
ACB   6.62 (-3.92%)
GILD   64.70 (-0.52%)
NFLX   466.00 (-0.89%)
DIS   129.83 (-0.30%)
BAC   25.50 (+0.59%)
BA   164.62 (-1.74%)
QQQ   266.42 (-1.44%)
AAPL   107.43 (-2.64%)
MSFT   198.83 (-2.01%)
FB   253.25 (-0.62%)
GOOGL   1,454.17 (-2.21%)
AMZN   2,949.35 (-1.97%)
NVDA   487.62 (-2.19%)
TSLA   440.00 (+3.91%)
BABA   274.00 (-0.62%)
CGC   16.49 (+0.55%)
GE   7.00 (-0.71%)
MU   50.99 (+0.02%)
AMD   74.92 (-2.13%)
T   29.05 (-0.07%)
F   7.29 (+0.14%)
ACB   6.62 (-3.92%)
GILD   64.70 (-0.52%)
NFLX   466.00 (-0.89%)
DIS   129.83 (-0.30%)
BAC   25.50 (+0.59%)
BA   164.62 (-1.74%)
Log in
NASDAQ:CODX

Co-Diagnostics Stock Forecast, Price & News

$14.83
+0.52 (+3.63 %)
(As of 09/18/2020 12:24 PM ET)
Add
Compare
Today's Range
$14.10
Now: $14.83
$14.99
50-Day Range
$8.24
MA: $16.46
$30.80
52-Week Range
$0.85
Now: $14.83
$30.99
Volume23,802 shs
Average Volume7.88 million shs
Market Capitalization$416.47 million
P/E Ratio82.39
Dividend YieldN/A
Beta-3.46
Co-Diagnostics, Inc., a molecular diagnostics company, intends to manufacture and sell reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules. It also intends to sell diagnostic equipment from other manufacturers as self-contained lab systems. The company was founded in 2013 and is headquartered in Salt Lake City, Utah.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.43 out of 5 stars


Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:CODX
CUSIPN/A
Phone801-438-1036

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$220,000.00
Book Value$0.10 per share

Profitability

Net Income$-6,200,000.00

Miscellaneous

Employees39
Market Cap$416.47 million
Next Earnings Date11/11/2020 (Estimated)
OptionableNot Optionable
$14.83
+0.52 (+3.63 %)
(As of 09/18/2020 12:24 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CODX News and Ratings via Email

Sign-up to receive the latest news and ratings for CODX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Co-Diagnostics (NASDAQ:CODX) Frequently Asked Questions

How has Co-Diagnostics' stock been impacted by COVID-19?

Co-Diagnostics' stock was trading at $13.19 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, CODX stock has increased by 11.2% and is now trading at $14.67.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Co-Diagnostics?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Co-Diagnostics in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Co-Diagnostics
.

When is Co-Diagnostics' next earnings date?

Co-Diagnostics is scheduled to release its next quarterly earnings announcement on Wednesday, November 11th 2020.
View our earnings forecast for Co-Diagnostics
.

How were Co-Diagnostics' earnings last quarter?

Co-Diagnostics Inc (NASDAQ:CODX) posted its earnings results on Thursday, August, 13th. The company reported $0.43 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.59 by $0.16. The business had revenue of $24.04 million for the quarter, compared to the consensus estimate of $27 million. Co-Diagnostics had a return on equity of 56.17% and a net margin of 31.42%.
View Co-Diagnostics' earnings history
.

What price target have analysts set for CODX?

2 analysts have issued 1 year price objectives for Co-Diagnostics' stock. Their forecasts range from $30.00 to $33.00. On average, they expect Co-Diagnostics' stock price to reach $31.50 in the next year. This suggests a possible upside of 114.7% from the stock's current price.
View analysts' price targets for Co-Diagnostics
.

Are investors shorting Co-Diagnostics?

Co-Diagnostics saw a increase in short interest in the month of August. As of August 31st, there was short interest totaling 7,850,000 shares, an increase of 18.0% from the August 15th total of 6,650,000 shares. Based on an average trading volume of 3,850,000 shares, the days-to-cover ratio is presently 2.0 days.
View Co-Diagnostics' Short Interest
.

Who are some of Co-Diagnostics' key competitors?

What other stocks do shareholders of Co-Diagnostics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Co-Diagnostics investors own include Inovio Pharmaceuticals (INO), Novavax (NVAX), Vaxart (VXRT), Moderna (MRNA), Gilead Sciences (GILD), Ibio (IBIO), Sorrento Therapeutics (SRNE), Pfizer (PFE), Johnson & Johnson (JNJ) and Tesla (TSLA).

Who are Co-Diagnostics' key executives?

Co-Diagnostics' management team includes the following people:
  • Mr. Dwight H. Egan, Chairman, CEO & Pres (Age 67, Pay $295k)
  • Dr. Brent C. Satterfield, Co-Founder & Chief Science Officer (Age 43, Pay $237.5k)
  • Mr. Reed L. Benson, CFO & Sec. (Age 72, Pay $215k)
  • Dr. Mayuranki Almaula, Sr. VP of Overseas Operations & Strategic Alliances
  • Mr. Cameron Gundry, Head of Commercialization LATAM/EUR

When did Co-Diagnostics IPO?

(CODX) raised $9 million in an initial public offering on Thursday, July 13th 2017. The company issued 1,300,000 shares at a price of $6.35-$6.75 per share. WallachBeth Capital and Network 1 Securities acted as the underwriters for the IPO.

What is Co-Diagnostics' stock symbol?

Co-Diagnostics trades on the NASDAQ under the ticker symbol "CODX."

Who are Co-Diagnostics' major shareholders?

Co-Diagnostics' stock is owned by many different retail and institutional investors. Top institutional investors include Vanguard Group Inc. (4.74%), Nuveen Asset Management LLC (0.79%), Barclays PLC (0.53%), Bank of New York Mellon Corp (0.36%), Advisory Services Network LLC (0.26%) and Virtu Financial LLC (0.25%). Company insiders that own Co-Diagnostics stock include Eugene Durenard and Richard S Serbin.
View institutional ownership trends for Co-Diagnostics
.

Which major investors are buying Co-Diagnostics stock?

CODX stock was acquired by a variety of institutional investors in the last quarter, including Vanguard Group Inc., Nuveen Asset Management LLC, Barclays PLC, Bank of New York Mellon Corp, Virtu Financial LLC, Charles Schwab Investment Management Inc., California Public Employees Retirement System, and Swiss National Bank.
View insider buying and selling activity for Co-Diagnostics
.

How do I buy shares of Co-Diagnostics?

Shares of CODX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Co-Diagnostics' stock price today?

One share of CODX stock can currently be purchased for approximately $14.67.

How big of a company is Co-Diagnostics?

Co-Diagnostics has a market capitalization of $411.98 million and generates $220,000.00 in revenue each year. The company earns $-6,200,000.00 in net income (profit) each year or ($0.36) on an earnings per share basis. Co-Diagnostics employs 39 workers across the globe.

What is Co-Diagnostics' official website?

The official website for Co-Diagnostics is www.codiagnostics.com.

How can I contact Co-Diagnostics?

Co-Diagnostics' mailing address is 2401 SOUTH FOOTHILL DRIVE SUITE D, SALT LAKE CITY UT, 84124. The company can be reached via phone at 801-438-1036 or via email at [email protected]

This page was last updated on 9/18/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.